[ad_1]
Joel Saget | French Media Agency
visits
On Friday night, the United States Food and Drug Administration (FDA for its acronym in English) approved the vaccine against covid-19 from Moderna laboratory for emergency use in the midst of the pandemic.
“The emergency use authorization allows Moderna’s vaccine to be distributed in the United States for individuals 18 years of age or older “, detailed the entity.
“After a person receives this vaccine, their body produces copies of the viral spicule, which does not cause the disease but causes the immune system to learn to react defensively, producing the response against SARS-CoV-2 ″, they explained.
According to the FDA, Moderna’s vaccine must be administered in two occasions per person, one month apart between each inoculation.
From the analysis in which more than 15 thousand volunteers participated, the firm noted that part of the sample had side effects after the second dose, among which were fatigue, headaches, muscles and joints, added to swollen glands in the same arm of the vaccine, vomiting and fever.
With this announcement, Moderna’s immunization became the second to receive the green light from the health authorities of that country after the product produced jointly by Pfizer and BioNtech.
“With the availability of two vaccines for the prevention of covid-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing high numbers of hospitalizations and deaths in the United States every day ”, celebrated Stephen Hahn, head of the organization.
[ad_2]
